Advances with the use of bio-inspired vectors towards creation of artificial viruses

Expert Opinion on Drug Delivery

Volumn 7, Issue 4, 2010, Pages 497-512

  McCarthy, Helen O ^a   Wang, Yuhua ^b   Mangipudi, Sriramchandra S ^b   Hatefi, Arash ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Bio inspired; Biomimetic; Gene delivery; Non viral; Recombinant vectors

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ADENOVIRUS VECTOR; AMPHOPHILE; ANION; ARTIFICIAL VIRUS VECTOR; BIOMIMETIC MATERIAL; CATION; DESIGNER BIOMIMETIC VECTOR; DNA CONDENSING PEPTIDE; HISTONE H1; HISTONE H2B; LENTIVIRUS VECTOR; LIPID; LIPOSOME; MACROGOL; PARVOVIRUS VECTOR; PEPTIDE; PLASMID DNA; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

AMINO ACID SEQUENCE; DNA VECTOR; DRUG RELEASE; GENE TARGETING; GENE VECTOR; HERPES SIMPLEX VIRUS 1; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; PROTEIN CONFORMATION; REVIEW; VIRAL GENE DELIVERY SYSTEM;

GENE THERAPY; GENETIC VECTORS; PEPTIDES; VIRUSES;

EID: 77949906661     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240903579989     Document Type: Review

References (102)

1. Mulligan RC. The basic science of gene therapy. Science 1993;260(5110):926-932
2. Louise C. Nonviral vectors. Methods Mol Biol 2006;333:201-226
3. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4(5):346-358
4. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet 2007;8(8):573-587
5. Hatefi A, Canine BF. Perspectives in vector development for systemic cancer gene therapy. Gene Ther Mol Biol 2009;13(A):15-19
6. Cronin J, Zhang X, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005;5(4):387-398
7. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288(5466):669-672
8. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348(3):255-256
9. Flotte TR. Recent developments in recombinant AAV-mediated gene therapy for lung diseases. Curr Gene Ther 2005;5(3):361-366
10. Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr Gene Ther 2007;7(5):316-324
11. Makower D, Rozenblit A, Kaufman H, et al. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin Cancer Res 2003;9(2):693-702
12. Bostanci A. Gene therapy. Blood test flags agent in death of Penn subject. Science 2002;295(5555):604-605
13. Schnell MA, Zhang Y, Tazelaar J, et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001;3(5 Pt 1):708-722
14. Thummala NR, Ghosh SS, Lee SW, et al. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronat eglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Gene Ther 2002;9(15):981-990
15. Shen Y, Nemunaitis J. Herpes simplex virus 1 (HSV-1) for cancer treatment. Cancer Gene Ther 2006;13(11):975-992
16. Green NK, Morrison J, Hale S, et al. Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. J Gene Med 2008;10(3):280-289
17. Herold BC, Visalli RJ, Susmarski N, et al. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol 1994;75(Pt 6):1211-1222
18. Argnani R, Boccafogli L, Marconi PC, et al. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide. Gene Ther 2004;11(13):1087-1098
19. Limbach KJ, Richie TL. Viral vectors in malaria vaccine development. Parasite Immunol 2009;31(9):501-519
20. Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J 2007;9(1):E92-104
21. Li S, Tseng WC, Stolz DB, et al. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 1999;6(4):585-594
22. Ambegia E, Ansell S, Cullis P, et al. Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim Biophys Acta 2005;1669(2):155-163
23. Ishida T, Ichihara M, Wang X, et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 2006;112(1):15-25
24. Judge A, McClintock K, Phelps JR, et al. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther 2006;13(2):328-337
25. Rejman J, Oberle V, Zuhorn IS, et al. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 2004;377(Pt 1):159-169
26. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995;92(16):7297-7301
27. Fischer D, Li Y, Ahlemeyer B, et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24(7):1121-1131
28. Lv H, Zhang S, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006;114(1):100-109
29. Fenske DB, MacLachlan I, Cullis PR. Long-circulating vectors for the systemic delivery of genes. Curr Opin Mol Ther 2001;3(2):153-158
30. Martin ME, Rice KG. Peptide-guided gene delivery. AAPS J 2007;9(1):E18-29
31. Pack DW, Hoffman AS, Pun S, et al. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4(7):581-593
32. Holm T, Johansson H, Lundberg P, et al. Studying the uptake of cell-penetrating peptides. Nat Protoc 2006;1(2):1001-1005
33. Keller M, Tagawa T, Preuss M, et al. Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu. Biochemistry 2002;41(2):652-659
34. Khadake JR, Rao MR. Condensation of DNA and chromatin by an SPKK-containing octapeptide repeat motif present in the C-terminus of histone H1. Biochemistry 1997;36(5):1041-1051
35. Dufourc EJ, Smith IC, Dufourcq J. Molecular details of melittin-induced lysis of phospholipid membranes as revealed by deuterium and phosphorus NMR. Biochemistry 1986;25(21):6448-6455
36. Durrer P, Galli C, Hoenke S, et al. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J Biol Chem 1996;271(23):13417-13421
37. Cochrane AW, Perkins A, Rosen CA. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J Virol 1990;64(2):881-885
38. Siomi H, Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J Cell Biol 1995;129(3):551-560
39. Murray KD, Etheridge CJ, Shah SI, et al. Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core. Gene Ther 2001;8(6):453-460
40. Wuthrich K, Billeter M, Braun W. Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances. J Mol Biol 1984;180(3):715-740
41. Keller M, Harbottle RP, Perouzel E, et al. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems. Chembiochem 2003;4(4):286-298
42. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997;272(25):16010-16017
43. Truant R, Cullen BR. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol Cell Biol 1999;19(2):1210-1217
44. Thoren PE, Persson D, Karlsson M, et al. The antennapedia peptide penetratin translocates across lipid bilayers-the first direct observation. FEBS Lett 2000;482(3):265-268
45. Wender PA, Mitchell DJ, Pattabiraman K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 2000;97(24):13003-13008
46. Rudolph C, Plank C, Lausier J, et al. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003;278(13):11411-11418
47. Soundara Manickam D, Bisht HS, Wan L, et al. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes. J Control Release 2005;102(1):293-306
48. Goparaju GN, Satishchandran C, Gupta PK. The effect of the structure of small cationic peptides on the characteristics of peptide-DNA complexes. Int J Pharm 2009;369(1-2):162-169
49. Foged C, Nielsen HM. Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin Drug Deliv 2008;5(1):105-117
50. Baake M, Doenecke D, Albig W. Characterisation of nuclear localisation signals of the four human core histones. J Cell Biochem 2001;81(2):333-346
51. Kaouass M, Beaulieu R, Balicki D. Histonefection: novel and potent non-viral gene delivery. J Control Release 2006;113(3):245-254
52. Kott M, Haberland A, Zaitsev S, et al. A new efficient method for transfection of neonatal cardiomyocytes using histone H1 in combination with DOSPER liposomal transfection reagent. Somat Cell Mol Genet 1998;24(4):257-261
53. Wagstaff KM, Fan JY, De Jesus MA, et al. Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting. FASEB J 2008;22(7):2232-2242
54. Monestier M. Autoantibodies to nucleosomes and histone-DNA complexes. Methods 1997;11(1):36-43
55. Jung HJ, Hwang DS, Wei QD, et al. Carassius auratus-originated recombinant histone H1 C-terminal peptide as gene delivery material. Biotechnol Prog 2008;24(1):17-22
56. Bharath MM, Ramesh S, Chandra NR, et al. Identification of a 34 amino acid stretch within the C-terminus of histone H1 as the DNA-condensing domain by site-directed mutagenesis. Biochemistry 2002;41(24):7617-7627
57. Rittner K, Benavente A, Bompard-Sorlet A, et al. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther 2002;5(2):104-114
58. Li W, Nicol F, Szoka FC Jr. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 2004;56(7):967-985
59. Wyman TB, Nicol F, Zelphati O, et al. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 1997;36(10):3008-3017
60. Futaki S, Masui Y, Nakase I, et al. Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes. J Gene Med 2005;7(11):1450-1458
61. Sakurai Y, Hatakeyama H, Akita H, et al. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system. Biol Pharm Bull 2009;32(5):928-932
62. Han J, Il Yeom Y. Specific gene transfer mediated by galactosylated poly-L-lysine into hepatoma cells. Int J Pharm 2000;202(1-2):151-160
63. Lee SH, Kim SH, Park TG. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem Biophys Res Commun 2007;357(2):511-516
64. Midoux P, Kichler A, Boutin V, et al. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjug Chem 1998;9(2):260-267
65. Escriou V, Carriere M, Scherman D, et al. NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv Drug Deliv Rev 2003;55(2):295-306
66. Suh J, Wirtz D, Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci USA 2003;100(7):3878-3882
67. Dean DA, Strong DD, Zimmer WE. Nuclear entry of nonviral vectors. Gene Ther 2005;12(11):881-890
68. Moroianu J, Blobel G, Radu A. Previously identified protein of uncertain function is karyopherin alpha and together with karyopherin beta docks import substrate at nuclear pore complexes. Proc Natl Acad Sci USA 1995;92(6):2008-2011
69. Lanford RE, Butel JS. Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 1984;37(3):801-813
70. Chan CK, Jans DA. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol Cell Biol 2002;80(2):119-130
71. Miller AM, Dean DA. Tissue-specific and transcription factor-mediated nuclear entry of DNA. Adv Drug Deliv Rev 2009;61(7-8):603-613
72. Bremner KH, Seymour LW, Logan A, et al. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug Chem 2004;15(1):152-161
73. Ludtke JJ, Zhang G, Sebestyen MG, et al. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J Cell Sci 1999;112 (Pt 12):2033-2041
74. Hariton-Gazal E, Feder R, Mor A, et al. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 2002;41(29):9208-9214
75. van der Aa M, Koning G, van der Gugten J, et al. Covalent attachment of an NLS-peptide to linear dna does not enhance transfection efficiency of cationic polymer based gene delivery systems. J Control Release 2005;101(1-3):395-397
76. Nagasaki T, Myohoji T, Tachibana T, et al. Can nuclear localization signals enhance nuclear localization of plasmid DNA? Bioconjug Chem 2003;14(2):282-286
77. Collins E, Birchall JC, Williams JL, et al. Nuclear localisation and pDNA condensation in non-viral gene delivery. J Gene Med 2007;9(4):265-274
78. Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999;96(1):91-96
79. Pollard H, Remy JS, Loussouarn G, et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 1998;273(13):7507-7511
80. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly (ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999;96(9):5177-5181
81. Tanimoto M, Kamiya H, Minakawa N, et al. No enhancement of nuclear entry by direct conjugation of a nuclear localization signal peptide to linearized DNA. Bioconjug Chem 2003;14(6):1197-1202
82. Malim MH, Hauber J, Le SY, et al. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989;338(6212):254-257
83. Mor A, Amiche M, Nicolas P. Structure, synthesis, and activity of dermaseptin b, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin. Biochemistry 1994;33(21):6642-6650
84. Pinol-Roma S, Dreyfuss G. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 1992;355(6362):730-732
85. Pollard VW, Michael WM, Nakielny S, et al. A novel receptor-mediated nuclear protein import pathway. Cell 1996;86(6):985-994
86. Subramanian A, Ranganathan P, Diamond SL. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat Biotechnol 1999;17(9):873-877
87. Ma H, Zhu J, Maronski M, et al. Non-classical nuclear localization signal peptides for high efficiency lipofection of primary neurons and neuronal cell lines. Neuroscience 2002;112(1):1-5
88. Tecle M, Preuss M, Miller AD. Kinetic study of DNA condensation by cationic peptides used in nonviral gene therapy: analogy of DNA condensation to protein folding. Biochemistry 2003;42(35):10343-10347
89. Paul RW, Weisser KE, Loomis A, et al. Gene transfer using a novel fusion protein, GAL4/invasin. Hum Gene Ther 1997;8(10):1253-1262
90. Fominaya J, Uherek C, Wels W. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor. Gene Ther 1998;5(4):521-530
91. Khalil IA, Kogure K, Akita H, et al. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 2006;58(1):32-45
92. Uherek C, Fominaya J, Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery. J Biol Chem 1998;273(15):8835-8841
93. Rajagopalan R, Xavier J, Rangaraj N, et al. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. J Gene Med 2007;9(4):275-286
94. Xavier J, Singh S, Dean DA, et al. Designed multi-domain protein as a carrier of nucleic acids into cells. J Control Release 2009;133(2):154-160
95. Varga CM, Wickham TJ, Lauffenburger DA. Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design. Biotechnol Bioeng 2000;70(6):593-605
96. Wang Y, Mangipudi SS, Canine BF, et al. A designer biomimetic vector with a chimeric architecture for targeted gene transfer. J Control Release 2009;137:46-53
97. Balicki D, Putnam CD, Scaria PV, et al. Structure and function correlation in histone H2A peptide-mediated gene transfer. Proc Natl Acad Sci USA 2002;99(11):7467-7471
98. Mangipudi SS, Canine BF, Wang Y, et al. Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells. Mol Pharm 2009;6(4):1100-1109
99. Canine BF, Wang Y, Hatefi A. Evaluation of the effect of vector architecture on DNA condensation and gene transfer efficiency. J Control Release 2008;129:117-123
100. Canine BF, Wang Y, Hatefi A. Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. J Control Release 2009;138(3):188-196
101. Hatefi A, Megeed Z, Ghandehari H. Recombinant polymer-protein fusion: a promising approach towards efficient and targeted gene delivery. J Gene Med 2006;8(4):468-476
102. Munkonge FM, Dean DA, Hillery E, et al. Emerging significance of plasmid DNA nuclear import in gene therapy. Adv Drug Deliv Rev 2003;55(6):749-760